AIRDF (Rocket Doctor AI) Equity-to-Asset: 0.46 (As of Mar. 2026) — 28% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AIRDF Rocket Doctor AI Inc AIRDF
29 GF Score
Price $0.45
! 7 Warning Signs
View Full Analysis

What is Rocket Doctor AI Equity-to-Asset?

Rocket Doctor AI AIRDF -1.16% 29 Equity-to-Asset is 0.46 as of Mar. 2026, which is 28% above its 10-year median of 0.36. GuruFocus rates AIRDF with a GF Score™ of 29/100. The stock has 7 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Rocket Doctor AI ranks worse than 52.27% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Rocket Doctor AI's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $4.53 Mil. Rocket Doctor AI's Total Assets for the quarter that ended in Mar. 2026 was $9.77 Mil. Therefore, Rocket Doctor AI's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.46.

The historical rank and industry rank for Rocket Doctor AI's Equity-to-Asset or its related term are showing as below:

AIRDF' s Equity-to-Asset Range Over the Past 10 Years
Min: -540.8   Med: 0.36   Max: 0.86
Current: 0.46

During the past 7 years, the highest Equity to Asset Ratio of Rocket Doctor AI was 0.86. The lowest was -540.80. And the median was 0.36.

AIRDF's Equity-to-Asset is ranked worse than
52.27% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs AIRDF: 0.46

Rocket Doctor AI  (OTCPK:AIRDF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Rocket Doctor AI Equity-to-Asset Related Terms


Rocket Doctor AI Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Rocket Doctor AI's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rocket Doctor AI Equity-to-Asset Chart

Rocket Doctor AI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial 0.12 -161.10 -1.00 0.62 0.33

Rocket Doctor AI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.44 0.48 0.33 0.46

AIRDF vs VEEV, BTSG, TEM: Equity-to-Asset Comparison

For the Health Information Services subindustry, Rocket Doctor AI's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rocket Doctor AI Equity-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Rocket Doctor AI's Equity-to-Asset falls into.


AIRDF
29GF Score
Rocket Doctor AI Inc AIRDF
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rocket Doctor AI Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Rocket Doctor AI's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=2.546/7.713
=0.33

Rocket Doctor AI's Equity to Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

Equity to Asset (Q: Mar. 2026 )=Total Stockholders Equity/Total Assets
=4.526/9.765
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.46 mean?
Rocket Doctor AI (AIRDF) has a Equity-to-Asset of 0.46 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Rocket Doctor AI and its competitors. This is 28% above median its historical median of 0.36. According to the industry distribution chart, Rocket Doctor AI ranks #357 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 52.3%.
Is Rocket Doctor AI's Equity-to-Asset too high?
Rocket Doctor AI's current Equity-to-Asset of 0.46 is 28% above median its 10-year median of 0.36. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Rocket Doctor AI's value of 0.46 is 4.2% below this industry median. Based on the distribution chart, Rocket Doctor AI ranks #357 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Rocket Doctor AI has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's Equity-to-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #357 out of 683 companies for Equity-to-Asset. This places Rocket Doctor AI in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Rocket Doctor AI's value of 0.46 is 4.2% below this benchmark. While the company's 10-year median is 0.36 vs. the industry median of 0.48, Rocket Doctor AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rocket Doctor AI's current Equity-to-Asset of 0.46 is 4.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current Equity-to-Asset is 0.46, which is 28% above median its own 10-year median of 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current Equity-to-Asset of 0.46. The current Equity-to-Asset is 0.46, which is 28% above median its 10-year median of 0.36 and 4.2% below the Healthcare Providers & Services industry median of 0.48. Rocket Doctor AI's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current Equity-to-Asset is 0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rocket Doctor AI Business Description

Other Exchanges 9390:GermanyAIDR:Canada
Address 700-838 W Hastings Street, Vancouver, BC, CAN, V6C 0A6
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
29GF Score

Get the complete analysis for AIRDF

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.45
Price